Search For "biotech"
Bharat Biotech starts phase III trials for COVAXIN
Updated : 5 years, 3 months ago IST
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Read More
Indian govt in talks with Moderna for its COVID-19 vaccine candidate
Updated : 5 years, 3 months ago IST
New Delhi[India], Nov 16 (ANI) Indian government is in dialogue with US biotech giant Moderna, regarding initial successful development of its COVID-19 vaccine candidate, which the drugmaker on Monday announced had achieved 94.5 per cent efficacy in phase 3 trials.
Read More
Encouraged to hear Moderna's efficacy results of COVID-19 vaccine: WHO
Updated : 5 years, 3 months ago IST
Geneva [Switzerland], November 16 (ANI/Sputnik): The World Health Organization (WHO) is encouraged to hear the announcement of the US biotech firm, Moderna, about the efficacy results of its coronavirus vaccine during its phase three clinical trials, its press office said on Monday.
Read More
COVID-19 vaccine: White House says 'big wins for all' as Pfizer, Moderna a
Updated : 5 years, 3 months ago IST
Washington DC [US], November 16 (ANI): After the US biotech company Moderna on Monday announced significant interim results of its Covid-19 vaccine, the White House credited US President Donald Trump for the progress of the vaccine which has been shown to be 94.5 per cent effective for the t
Read More
Moderna's Covid-19 vaccine is 94.5 pc effective
Updated : 5 years, 3 months ago IST
Massachusetts [US], November 16 (ANI): US biotech company Moderna on Monday announced a new potential Covid-19 vaccine, which has been shown to be 94.5 per cent effective at protecting people from coronavirus, according to interim results from late-stage clinical trials.
Read More
Study focuses on identification of SARS-CoV-2 virus features causing COVID
Updated : 5 years, 4 months ago IST
Seoul [South Korea], November 15 (ANI): Features of the SARS-CoV-2 virus causing COVID-19, which could be useful for developing vaccines and treatment strategies, were identified using a nonhuman primate model developed at the Korea Research Institute of Bioscience and Biotechnology (KRIBB).
Read More
Pfizer says its coronavirus vaccine more than 90 pc effective in first ana
Updated : 5 years, 4 months ago IST
Washington [US], November 9 (ANI): The coronavirus vaccine developed by drug giant American Pfizer and German biotechnology firm BioNTech was more than 90 per cent effective at protecting people from infection as compared to placebo saline shot, according to an analysis.
Read More
Bharat Biotech to manufacture 10 types of vaccines, including COVID-19, in
Updated : 5 years, 4 months ago IST
Bhubaneswar (Odisha) [India], November 7 (ANI): Bharat Biotech International Ltd (BBIL) is going to manufacture ten types of vaccines including malaria and the novel coronavirus in its upcoming unit here, Chairman and Managing Director Dr. Krishna Ella said while attending a virtual meeti
Read More
With 1000+ offers; Campus Placements for 2021 batch shoots off to a flying
Updated : 5 years, 4 months ago IST
Chandigarh (Punjab) [India], October 27 (ANI/PRNewswire): The Campus Placements for the 2021 batch at Chandigarh University Gharuan kicked-off to a flying start and touched 1000+ offers within three months of the first phase of the placement season. Chandigarh University continued to be a tr
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 4 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 4 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More
The Rockefeller Foundation awards new grants to scale up COVID-19 testing
Updated : 5 years, 4 months ago IST
New York [USA], October 19 (ANI/NewsVoir): To support the expansion of COVID-19 testing and contact tracing across India, The Rockefeller Foundation announced two new grants to The Center for Cellular and Molecular Platforms and PATH.
Read More